首页> Clinical genitourinary cancer> Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.

Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sonia,Vallet

第一单位： Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.

作者： Sonia,Vallet ^[1] ; Sascha,Pahernik ^[2] ; Thomas,Höfner ^[3] ; Georgi,Tosev ^[2] ; Boris,Hadaschik ^[2] ; Stefan,Duensing ^[4] ; Oliver,Sedlaczek ^[5] ; Markus,Hohenfellner ^[2] ; Dirk,Jäger ^[1] ; Carsten,Grüllich ^[6] ; Renal Cancer Center at the National Center for Tumor Diseases (NCT) Heidelberg, Germany

作者单位： Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, Heidelberg University Hospital, Heidelberg, Germany. ^[1] Department of Urology, Heidelberg University Hospital, Heidelberg, Germany. ^[2] Department of Urology, Theresienkrankenhaus, and St. Hedwig-Klinik GmbH, Mannheim, Germany. ^[3] Department of Urology, Section of Molecular Urooncology, Heidelberg University Hospital, Heidelberg, Germany. ^[4] Department of Radiology, Heidelberg University Hospital, Heidelberg, Germany. ^[5] Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: carsten.gruellich@med.uni-heidelberg.de. ^[6]

关键词 Metastatic kidney cancer Multiple lines of treatment Objective response Survival Targeted therapy